TYVCODO Trademark

Trademark Overview


On Tuesday, May 11, 2021, a trademark application was filed for TYVCODO with the United States Patent and Trademark Office. The USPTO has given the TYVCODO trademark a serial number of 79321251. The federal status of this trademark filing is REGISTERED as of Tuesday, June 28, 2022. This trademark is owned by NOVARTIS AG. The TYVCODO trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
tyvcodo

General Information


Serial Number79321251
Word MarkTYVCODO
Filing DateTuesday, May 11, 2021
Status700 - REGISTERED
Status DateTuesday, June 28, 2022
Registration Number6770234
Registration DateTuesday, June 28, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2022

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSandoz AG
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Friday, January 19, 2024CHANGE OF OWNER RECEIVED FROM IB
Tuesday, November 1, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, October 12, 2022FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, October 12, 2022FINAL DISPOSITION PROCESSED
Wednesday, September 28, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 28, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 28, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, April 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 12, 2022PUBLISHED FOR OPPOSITION
Wednesday, March 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, March 5, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 28, 2022REFUSAL PROCESSED BY IB
Thursday, February 10, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 9, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 9, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 8, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, February 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 4, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, February 4, 2022REFUSAL PROCESSED BY MPU
Thursday, January 13, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, January 12, 2022NON-FINAL ACTION WRITTEN
Wednesday, January 12, 2022ASSIGNED TO EXAMINER
Tuesday, October 12, 2021APPLICATION FILING RECEIPT MAILED
Wednesday, October 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 30, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, September 30, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB